However, when the tumor cells were also stimulated with the type 1 cytokine IFNγ and TNFα an increased expression of CCL2, CCL5, CXCL9, CXCL10 and IL-6 was detected when compared to treatment with the control antibody (Fig 1A). The gene discussed is CCL5; the disease is neoplasm.